Pancreatic cancer is deadly and difficult to treat. A new pill could change that - PBS
Hannah Grabenstein Hannah Grabenstein A new drug that targets a gene behind pancreatic cancer has physicians and researchers cautiously optimistic about improved treatment for one of the deadliest cancers. Revolution Medicines, the pharmaceutical company behind the new drug, will release more in-depth data Sunday on the clinical trial testing of its pill.